{"schema_version":"alpha-profile-public-v1","slug":"lavina-talukdar-cfa","canonical_url":"https://registry.alpha.ac/people/lavina-talukdar-cfa","as_of":"2026-09-21T00:06:15.476718+00:00","published_at":"2026-09-02T02:37:22.620298+00:00","last_reviewed_at":"2026-05-16T01:12:00.726+00:00","identity":{"display_name":"Lavina Talukdar, CFA","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Monopar Therapeutics","company_slug":"monopar-therapeutics","exchange":"NASDAQ","ticker":"MNPR","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2025-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","effective_date":"2025-04-30","last_checked_at":"2026-04-28T23:29:00.777+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=lavina-talukdar-cfa","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=lavina-talukdar-cfa&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Over 20 years of experience in healthcare and biotechnology investing and financial strategy. Currently Senior Vice President, Head of Investor Relations at Moderna since April 2019. Previously Senior Portfolio Manager at Abu Dhabi Investment Authority overseeing global healthcare investments, Partner and Healthcare Equity Analyst at Lord Abbett & Co., and investment roles at MFS Investment Management and State Street Global Advisors."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Monopar Therapeutics","organizationId":"monopar-therapeutics","title":"Director","period":"2025-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Monopar Therapeutics","company_slug":"monopar-therapeutics","exchange":"NASDAQ","ticker":"MNPR","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2025-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","effective_date":"2025-04-30","last_checked_at":"2026-04-28T23:29:00.777+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Lavina Talukdar, CFA as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:12:00.891959+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MNPR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","published_at":"2025-04-30T00:00:00+00:00","last_checked_at":"2026-05-16T01:12:00.785865+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Lavina Talukdar, CFA currently serves as Director at Monopar Therapeutics.","claim_state":"verified","valid_from":"2025-04-30","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:12:00.852656+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MNPR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","published_at":"2025-04-30T00:00:00+00:00","last_checked_at":"2026-05-16T01:12:00.785865+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit","Compensation","Nominating/Governance","Plan Administrator Committee"],"claim_text":"Lavina Talukdar, CFA serves on Audit, Compensation, Nominating/Governance, Plan Administrator Committee.","claim_state":"verified","valid_from":"2025-04-30","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:12:00.86945+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MNPR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","published_at":"2025-04-30T00:00:00+00:00","last_checked_at":"2026-05-16T01:12:00.785865+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Moderna","claim_text":"Lavina Talukdar, CFA is linked to Moderna as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:12:00.994357+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MNPR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","published_at":"2025-04-30T00:00:00+00:00","last_checked_at":"2026-05-16T01:12:00.785865+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Senior Vice President, Head of Investor Relations","claim_text":"Lavina Talukdar, CFA is also listed as Senior Vice President, Head of Investor Relations.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:12:00.97843+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MNPR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","published_at":"2025-04-30T00:00:00+00:00","last_checked_at":"2026-05-16T01:12:00.785865+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Lavina Talukdar, CFA as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:12:00.925657+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MNPR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","published_at":"2025-04-30T00:00:00+00:00","last_checked_at":"2026-05-16T01:12:00.785865+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Lavina Talukdar, CFA as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:12:00.909274+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MNPR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","published_at":"2025-04-30T00:00:00+00:00","last_checked_at":"2026-05-16T01:12:00.785865+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:lavina-talukdar-cfa","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2025-01-01 · current","organization":"Monopar Therapeutics","organization_id":"monopar-therapeutics"},"claim_text":"Director at Monopar Therapeutics (2025-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/lavina-talukdar-cfa#profile","url":"https://registry.alpha.ac/people/lavina-talukdar-cfa","dateModified":"2026-05-16T01:12:00.726+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/lavina-talukdar-cfa#person","name":"Lavina Talukdar, CFA","url":"https://registry.alpha.ac/people/lavina-talukdar-cfa","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Monopar Therapeutics","tickerSymbol":"NASDAQ: MNPR"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2025-01-01","memberOf":{"@type":"Organization","name":"Monopar Therapeutics","url":"https://registry.alpha.ac/companies/monopar-therapeutics","tickerSymbol":"NASDAQ: MNPR"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","name":"MNPR DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/lavina-talukdar-cfa"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T01:12:00.726+00:00","observed_at":"2026-09-21T00:06:15.476718+00:00","freshness_days":128}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"lavina-talukdar-cfa","canonical_url":"https://registry.alpha.ac/people/lavina-talukdar-cfa"},"publication":{"published_at":"2026-09-02T02:37:22.620298+00:00","last_reviewed_at":"2026-05-16T01:12:00.726+00:00","as_of":"2026-09-21T00:06:15.476718+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/lavina-talukdar-cfa","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/lavina-talukdar-cfa","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/lavina-talukdar-cfa.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}